SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

PSTI RSS Feed
Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017, patentminer2013, n3m3sis
Search This Board: 
Last Post: 6/27/2017 5:10:14 PM - Followers: 133 - Board type: Free - Posts Today: 5

 

Pluristem Therapeutics Inc. (Nasdaq: PSTI) 

 

 

http://www.pluristem.com/

 

 


 

Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172
E-Mail: info@pluristem.com

 

CIK:  0001158780

 

Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 

 

Management: 

http://www.pluristem.com/index.php/about2/management.html
 

Clinical Program: 

http://www.pluristem.com/index.php/clinic-program.html


Recent News and Press:

http://www.pluristem.com/index.php/press-room.html

http://finance.yahoo.com/q/h?s=PSTI+Headlines

http://seekingalpha.com/symbol/PSTI

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001158780&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany


 

 

 

Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501

 

Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America
karinek@pluristem.com


 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

PSTI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI News: Securities Registration Statement (simplified Form) (s-3) 06/23/2017 08:48:56 AM
PSTI News: Statement of Changes in Beneficial Ownership (4) 06/23/2017 08:33:05 AM
PSTI News: Statement of Changes in Beneficial Ownership (4) 06/23/2017 08:30:22 AM
PSTI News: Statement of Changes in Beneficial Ownership (4) 06/23/2017 08:28:51 AM
PSTI News: Current Report Filing (8-k) 06/23/2017 08:11:23 AM
PostSubject
#4193  Sticky Note Here is the Seeking Alpha interview which is patentminer2013 03/04/17 05:43:28 PM
#5643   Excerpt From Pluristem's Feb 13,2017 Press Release ! FDApproved 06/27/17 05:10:14 PM
#5642   Actually "Open Label" has nothing to do with Melon4head 06/27/17 04:58:18 PM
#5641   Official Title: A Phase I Open-label Dose-escalation Study FDApproved 06/27/17 03:48:42 PM
#5640   There was a recent nuclear accident at a n3m3sis 06/27/17 03:12:49 PM
#5639   According to clinical trials dot gov, the Phase SrdghJack 06/27/17 02:58:33 PM
#5638   Japan’s Laws Supporting Accelerated Pathways for Cell Therapies FDApproved 06/26/17 02:33:13 PM
#5637   Why would they split the company for the Scott999 06/26/17 11:51:37 AM
#5636   Should be titled "How not to make money Scott999 06/26/17 11:25:48 AM
#5635   Pluristem Is Presenting Tomorrow In Boston From: 12:00 FDApproved 06/26/17 11:14:10 AM
#5634   WOW, they also updated this page on web bluehorsesho 06/25/17 07:14:13 PM
#5633   Glad you enjoyed it, did you notice that bluehorsesho 06/25/17 01:06:04 PM
#5632   Blue... That Was The Best Post Ever ! You FDApproved 06/25/17 12:27:27 PM
#5631   Yes, R&D machine, but we all need them bluehorsesho 06/25/17 11:27:38 AM
#5630   Intellectual Property FDApproved 06/25/17 11:22:54 AM
#5629   Pluristem Is An R&D Machine. FDApproved 06/25/17 11:12:37 AM
#5628   I hope we become the next disruptive company... bluehorsesho 06/25/17 09:36:22 AM
#5627   New Pluristem Marketing Video Out This Morning on FDApproved 06/25/17 04:20:38 AM
#5626   My wife worked for Yahoo in CA in Melon4head 06/24/17 09:37:29 PM
#5625   Thanks, WE MUST be Next, how did I bluehorsesho 06/24/17 07:59:27 PM
#5624   Blue..You Are Slacking-Off In The DD Department ! FDApproved 06/24/17 07:31:46 PM
#5623   will Z&Y give employees some of those grants..... bluehorsesho 06/24/17 06:11:45 PM
#5622   Regulatory Recon: Google, Novartis Back Medicxi's $300M Biotech bluehorsesho 06/24/17 01:20:29 PM
#5621   FDA warp speed RMAT approval nukes stem cell bluehorsesho 06/24/17 01:18:38 PM
#5620   NCI Drug Dictionary bluehorsesho 06/24/17 01:08:42 PM
#5619   To: thesaud... FDApproved 06/24/17 12:09:18 PM
#5618   I just hope its not for what they thesaud 06/24/17 10:18:39 AM
#5617   should I order my New 2017 Model X today.... bluehorsesho 06/24/17 10:14:21 AM
#5616   My Thoughts Exactly ! FDApproved 06/24/17 08:51:34 AM
#5615   I have found it Very Intersting..... n3m3sis 06/24/17 08:29:15 AM
#5614   I Find It Interesting.... FDApproved 06/23/17 08:08:30 PM
#5613   my only concern, without being to [sic] negative......... zzaatt 06/23/17 06:00:56 PM
#5612   thanks, nice to be back zzaatt 06/23/17 05:57:12 PM
#5611   The More I Ponder The 2 CEO.. 2 FDApproved 06/23/17 05:48:20 PM
#5610   It's more than just coincidence for sure.... bluehorsesho 06/23/17 05:37:57 PM
#5609   Yes, I Saw That, It Almost Seems To FDApproved 06/23/17 05:30:27 PM
#5608   Aug 23 at MHSRS, Army ARS event and this... bluehorsesho 06/23/17 05:27:14 PM
#5607   Yes, All 3 Zami,Yaky And Erez Have Worked FDApproved 06/23/17 05:05:02 PM
#5606   Interesting thought, I could see them creating.... bluehorsesho 06/23/17 04:38:34 PM
#5605   Food For Thought ! FDApproved 06/23/17 04:27:30 PM
#5604   thanks, nice to be back, I had 1 foot.... bluehorsesho 06/23/17 02:57:36 PM
#5603   Welcome back, Blue. sekander 06/23/17 01:06:48 PM
#5601   UP 5 CENTS Now, come on day traders !!! bluehorsesho 06/23/17 12:10:51 PM
#5599   WOW, down 14 cents zzaatt 06/23/17 11:53:58 AM
#5598   I Meant To Say A Huge Stock Grant FDApproved 06/23/17 11:48:50 AM
#5597   They Must Have Got A BIG DEAL DONE FDApproved 06/23/17 11:33:14 AM
#5596   yes, but they NEVER had this many late stage... bluehorsesho 06/23/17 11:32:19 AM
#5595   We have seen large S-3 filings before that SrdghJack 06/23/17 11:12:06 AM
#5594   I See Any Future Warrants If Any, Are FDApproved 06/23/17 10:43:21 AM
#5593   That was a good buying opportunity! D theG 06/23/17 10:31:53 AM
#5592   Very Impressive comeback from 14 cents down... bluehorsesho 06/23/17 10:29:40 AM
PostSubject